These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 14219537)
21. The variability of individual tolerance to methotrexate in cancer patients. Hansen HH; Selawry OS; Holland JF; McCall CB Br J Cancer; 1971 Jun; 25(2):298-305. PubMed ID: 4256007 [TBL] [Abstract][Full Text] [Related]
22. EXPERIMENTAL CHEMOTHERAPY STUDIES. V. THE COLLATERAL SENSITIVITY TO ALKYLATING AGENTS OF SEVERAL ANTIMETABOLITE-RESISTANT ASCITES TUMORS IN MICE. RUTMAN RJ Cancer Res; 1964 May; 24():634-8. PubMed ID: 14188466 [No Abstract] [Full Text] [Related]
23. Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer. Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG Cancer Chemother Rep; 1972 Feb; 56(1):95-101. PubMed ID: 5030811 [No Abstract] [Full Text] [Related]
24. A METHYLHYDRAZINE DERIVATIVE IN HODGKIN'S DISEASE AND OTHER MALIGNANT NEOPLASMS. THERAPEUTIC AND TOXIC EFFECTS STUDIED IN 51 PATIENTS. BRUNNER KW; YOUNG CW Ann Intern Med; 1965 Jul; 63():69-86. PubMed ID: 14305970 [No Abstract] [Full Text] [Related]
30. COMPARISON OF HIGH-DOSAGE AND LOW-DOSAGE-MAINTENANCE THERAPY WITH 5-FLUOROURACIL IN SOLID TUMORS. CUDMORE JT; GROESBECK HP Cancer; 1964 Feb; 17():230-2. PubMed ID: 14123683 [No Abstract] [Full Text] [Related]
31. SYSTEMIC THERAPY WITH AMETHOPTERIN IN SQUAMOUS CARCINOMA OF THE HEAD AND NECK. PAPAC RJ; JACOBS EM; FOYE LV; DONOHUE DM Cancer Chemother Rep; 1963 Oct; 32():47-54. PubMed ID: 14088835 [No Abstract] [Full Text] [Related]
32. SYSTEMIC THIOSULFATE PROTECTION DURING FRACTIONATED REGIONAL NITROGEN MUSTARD THERAPY. LAWRENCE W; TAYAO MS; MAHAJAN RD; PAGE R; MILLER DG; CLAPP P J Surg Res; 1964 Nov; 4():483-94. PubMed ID: 14224011 [No Abstract] [Full Text] [Related]
33. COMBINED USE OF AB-132 (METUREDEPA, TURLOC) AND X-IRRADIATION IN THE MANAGEMENT OF ADVANCED BRONCHOGENIC CARCINOMA. VELASCO HA; ROSS CA; WEBSTER JH; SOKAL JE; STUTZMAN L; AMBRUS JL Cancer; 1964 Jul; 17():841-9. PubMed ID: 14184043 [No Abstract] [Full Text] [Related]
34. THE CLINICAL RESULT OF CHEMOTHERAPY WITH ENDOXAN. GERHARTZ H Acta Unio Int Contra Cancrum; 1964; 20():366-8. PubMed ID: 14151931 [No Abstract] [Full Text] [Related]
35. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: MULTIPLE MYELOMA AND LYMPHOMA. DAVIS P Cancer Chemother Rep; 1964 Aug; 40():51-2. PubMed ID: 14206919 [No Abstract] [Full Text] [Related]
36. HYDROXYUREA (NSC-32065): RESULTS OF A PHASE I STUDY. GRIFFITH KM Cancer Chemother Rep; 1964 Aug; 40():33-6. PubMed ID: 14206912 [No Abstract] [Full Text] [Related]
37. [ON TRENIMON THERAPY OF MALIGNANT TUMORS IN UROLOGY]. GUNST W Med Welt; 1963 Oct; 43():2190-1. PubMed ID: 14093065 [No Abstract] [Full Text] [Related]
38. 6-THIOGUANINE (NSC-752)-1 THERAPY IN PATIENTS WITH MULTIPLE MYELOMA. CARBONE PP; FREI E; OWENS AH; OLSON KB; MILLER SP Cancer Chemother Rep; 1964 Mar; 36():59-62. PubMed ID: 14152276 [No Abstract] [Full Text] [Related]
39. METABOLIC EFFECTS OF 9-BUTYL-6-THIOGUANINE IN VIVO. KIMBALL AP; LEPAGE GA Cancer Res; 1963 Dec; 23():1792-9. PubMed ID: 14082874 [No Abstract] [Full Text] [Related]
40. FLUOROMETHOLONE (NSC-33001) AS A PALLIATIVE IN ADVANCED GASTROINTESTINAL CARCINOMA. MOERTEL CG; REITEMEIER RJ; HAHN RG; BLACKBURN CM Cancer Chemother Rep; 1964 Dec; 43():25-7. PubMed ID: 14250648 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]